Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

ELV partners with NACHC to bring Food as Medicine into primary care, targeting nutritional insecurities and chronic disease.

Investors in Elevance Health Inc (Symbol: ELV) saw new options begin trading today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is ...

On January 16, Andrew Mok CFA from Barclays maintained a buy rating on ELV with a price target of $501. Overall ELV ranks 8th on our list of the best large-cap value stocks to buy in 2025.

Elevance Health (ELV) stock is one of the worst S&P 500 stocks in Thursday's session. The selloff comes after the health insurance company missed bottom-line expectations for its third quarter and ...

Elevance Health, Inc. (ELV) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

Elevance Health's revenue of $44.7 billion in Q3 reflects a 5.3% y-o-y growth, led by a solid 15% rise in Carelon sales. Carelon includes Carelon Rx and Carelon Services. The segment growth can be ...

Elevance Health ELV 3.71% earnings fell short of Wall Street projections in the latest sign of how medical expenses are squeezing insurers’ government businesses, a result that punished shares ...